RightFit
RecruitingNot applicable

Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic Evaluation

ADVANTAGE: Addressing Disparities for Veterans and African Americans Through Peer-Navigation for Testing and Genetic Evaluation

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
18 Years and older
Sex
Male only
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

Not stated in the study description — ask the study team about visits and procedures.

Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether a trained peer helper helps African American men better understand and take part in genetic testing. It compares having a helper with not having one. It focuses on men whose prostate cancer has spread, but men who meet other listed genetic testing rules may also join.

This clinical trial evaluates whether having a trained peer navigator helps African American men with prostate cancer that has spread to other parts of the body (metastatic) understand and navigate the genetic testing process better than not having a peer navigator. Genetic testing for men with prostate cancer is very important for making treatment and management decisions. However, understanding the risks, benefits, and steps of genetic counseling and testing can be very challenging for patients. African American men are especially less likely to participant in genetic testing due to lack of awareness or understanding, cultural beliefs, finances, or mistrust of the healthcare system. A peer navigator, someone who helps a patient through the information and the process, may be helpful to some men. This study evaluates whether having a peer navigator throughout the genetic evaluation process helps patients understand and engage in the process more.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Be an African American man age 18 or older.
  • Speak English.
  • Sign and date a form agreeing to join the study.
  • Be willing to follow all study steps and stay available for the whole study.
  • Meet at least one of these genetic testing rules: prostate cancer that has spread to other parts of the body; ductal or intraductal cancer (types involving prostate ducts); stage T3a or higher (cancer growing outside the prostate); grade group 4 or Gleason score 8 or higher (scores showing how abnormal the cancer cells look); or the family history listed below.
  • The family history rule is breast, ovarian, prostate, pancreatic, colorectal (colon or rectum), or uterine (womb) cancer in 3 or more blood relatives, especially if diagnosed before age 50.

Who can't join

  • Do not meet the rules for joining, including being under age 18.
  • Have trouble understanding the form agreeing to join the study.
  • Have significant anxiety noticed during the process of agreeing to join.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: * Provide signed and dated informed consent form * English speaking only * Willing to comply with all study procedures and be available for the duration of the study * Any individual \>= 18 years old * African American men who meet National Comprehensive Cancer Network (NCCN) criteria for testing will be offered participation. These criteria include any one of the following: (1) metastatic prostate cancer (PCA); (2) intraductal or ductal pathology; (3) T3a or higher; (4) grade group 4 or Gleason 8 or higher; (5) family history of breast, ovarian, prostate, pancreatic, colorectal, or uterine cancers in 3 or more blood relatives particularly if diagnosed at age \< 50. These criteria have been adapted from the NCCN Prostate Cancer (version 2.2021) and NCCN Breast, Ovarian, and Pancreatic (version 2.2021) guideline Exclusion Criteria: * Patients that do not meet the inclusion criteria and children under the age of 18 will be excluded * Anyone who has trouble understanding the consent or with significant anxiety detected during the consent process will also be excluded

Study sites (1)

PA